Ling‐Wen Ding

5.8k citations

61 papers · 2.3k · 1 hit paper · h-index 27

Impact in

Geriatrics and Gerontology top 2%
Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation

Papers in

Molecular Biology 35
- Ubiquitin and proteasome pathways 5
- Cancer-related gene regulation 5
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 4
Cancer Research 12
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 5

Co-authors: H. Phillip Koeffler (32 shared papers)De‐Chen Lin (18 shared papers)Boon Cher Goh (7 shared papers)Xiaoqiang Xiang (4 shared papers)Lingzhi Wang (5 shared papers)Paul C. Ho (2 shared papers)Pei Shi Ong (2 shared papers)Qiao‐Yang Sun (16 shared papers)
Journals: Cancer Research (10 papers)Advanced Materials (4 papers)Blood (3 papers)British Journal of Cancer (3 papers)Oncogene (3 papers)
Partner nations: Singapore China United States

In The Last Decade

Ling‐Wen Ding

58 papers receiving 2.3k citations

Ling‐Wen Ding's Hit Papers

align trajectories log scale

Resveratrol for cancer therapy: Challenges and future perspectives 2021 · 365 citations

Peers

Countries citing papers authored by Ling‐Wen Ding

Since Specialization

Citations

This map shows the geographic impact of Ling‐Wen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Wen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Wen Ding more than expected).

Fields of papers citing papers by Ling‐Wen Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Wen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Wen Ding. The network helps show where Ling‐Wen Ding may publish in the future.

Co-authors

The 25 scholars most cited alongside Ling‐Wen Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling‐Wen Ding Line = papers co-authored together Ling‐Wen Ding links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Resveratrol for cancer therapy: Challenges and future perspectives Cancer Letters ·Boxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu, Zhaowu Ma, Muthu K. Shanmugam, Ling‐Wen Ding, Xiaoqiang Xiang, Paul C. Ho, Lingzhi Wang, Pei Shi Ong, Boon Cher Goh Hit paper breakdown →	2021	365
2	Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma Gut ·Yan-Yi Jiang, De‐Chen Lin, Anand Mayakonda, Masaharu Hazawa, Ling‐Wen Ding, Wen-Wen Chien, Liang Xu, Ye Chen, Jin‐Fen Xiao, William Senapedis, Erkan Baloglu, Deepika Kanojia, Shang Li, Xin Xu, Henry Yang, Jeffrey Tyner, Ming‐Rong Wang, H. Phillip Koeffler	2016	171
3	Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma Cancer Research ·De‐Chen Lin, Anand Mayakonda, Huy Q. Dinh, Pinbo Huang, Lehang Lin, Xiaoping Liu, Ling‐Wen Ding, Jie Wang, Benjamin P. Berman, Erwei Song, Dong Yin, H. Phillip Koeffler	2017	151
4	Celastrol in cancer therapy: Recent developments, challenges and prospects Cancer Letters ·Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, Arul Goel, Ling‐Wen Ding, Andrea Li‐Ann Wong, Paul C. Ho, Gautam Sethi, Xiaoqiang Xiang, Boon Cher Goh	2021	98
5	Ultrathin Clay Nanoparticles‐Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy Advanced Materials ·Jianping Liu, Jiezhao Zhan, Ye Zhang, Lin Huang, H. J. Yang, Jie Feng, Ling‐Wen Ding, Zheyu Shen, Xiaoyuan Chen	2023	94
6	Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas Gut ·De‐Chen Lin, Huy Q. Dinh, Jian‐Jun Xie, Anand Mayakonda, Tiago C. Silva, Yan‐Yi Jiang, Ling‐Wen Ding, Jianzhong He, Xiu‐E Xu, Jia‐Jie Hao, Ming‐Rong Wang, Chunquan Li, Li‐Yan Xu, En‐Min Li, Benjamin P. Berman, H. Phillip Koeffler	2017	86
7	Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma Cancer Research ·Yuan Jiang, Yan-Yi Jiang, Anand Mayakonda, Moli Huang, Ling‐Wen Ding, Lin Han, Fenggang Yu, Yanan Lu, Thomas Kwok Seng Loh, M Chow, Samantha L. Savage, Jeffrey Tyner, De‐Chen Lin, H. Phillip Koeffler	2017	78
8	Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells Oncotarget ·Wenwen Chien, Ling‐Wen Ding, Qiao‐Yang Sun, Lucia Torres Fernández, (unknown), Jin-Fen Xiao, Su Lin Lim, Manoj Garg, Kian Leong Lee, Shojiro Kitajima, Sumiko Takao, Wei Zhong Leong, Haibo Sun, Itay Tokatly, Lorenz Poellinger, Sigal Gery, Phillip H. Koeffler	2014	73
9	An Integrated Polymeric mRNA Vaccine without Inflammation Side Effects for Cellular Immunity Mediated Cancer Therapy Advanced Materials ·Pei Huang, Lingsheng Jiang, Hui Pan, Ling‐Wen Ding, Bo Zhou, Mengyao Zhao, Jianhua Zou, Benhao Li, Meiwei Qi, Hongzhang Deng, Yongfeng Zhou, Xiaoyuan Chen	2022	72
10	Laminin-5γ-2 (LAMC2) Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Progression, Migration, and Invasion by Modulating Signaling of EGFR The Journal of Clinical Endocrinology & Metabolism ·Manoj Garg, Deepika Kanojia, Ryoko Okamoto, Saket Jain, Vikas Madan, Wenwen Chien, Abhishek Sampath Kumar, Ling‐Wen Ding, Meng Xuan, Jonathan Said, Ngan Doan, Lizhen Liu, Henry Yang, Sigal Gery, Glenn D. Braunstein, H. Phillip Koeffler	2013	64
11	SOX7 is down-regulated in lung cancer Journal of Experimental & Clinical Cancer Research ·Takahide Hayano, Manoj Garg, Dong Yin, Makoto Sudo, Norihiko Kawamata, Shuo Shi, Wenwen Chien, Ling‐Wen Ding, Geraldine Leong, Seiichi Mori, Dong Xie, Patrick Tan, H. Phillip Koeffler	2013	63
12	Using silica particles to isolate total RNA from plant tissues recalcitrant to extraction in guanidine thiocyanate Analytical Biochemistry ·Ling‐Wen Ding, Qiao‐Yang Sun, Zhaoyu Wang, Yong-Bin Sun, Zeng‐Fu Xu	2007	62
13	A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma Cancer Research ·Sai Ma, Bo Zhou, Qian Yang, Yunzhi Pan, Wei Yang, Stephen J. Freedland, Ling‐Wen Ding, Michael R. Freeman, Joshua J. Breunig, Neil A. Bhowmick, Jian Pan, H. Phillip Koeffler, De‐Chen Lin	2021	60
14	Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells Biomedicine & Pharmacotherapy ·Hélène Marijon, (unknown), Ling‐Wen Ding, Haibo Sun, Sigal Gery, Aimery de Gramont, H. Phillip Koeffler	2018	60
15	Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer Molecular Oncology ·Wenwen Chien, Qiao‐Yang Sun, Kian Leong Lee, Ling‐Wen Ding, Peer Wuensche, Lucia Torres Fernández, (unknown), Itay Tokatly, Norazean Zaiden, Lorenz Poellinger, Seiichi Mori, Henry Yang, Jeffrey Tyner, H. Phillip Koeffler	2015	57
16	KPT-330 has antitumour activity against non-small cell lung cancer British Journal of Cancer ·Haibo Sun, Norimichi Hattori, Wenwen Chien, Qiao‐Yang Sun, Makoto Sudo, G L E-Ling, Ling‐Wen Ding, Su Lin Lim, Sharon Shacham, Michael Kauffman, Tsuyoshi Nakamaki, H. Phillip Koeffler	2014	53
17	Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma Cancer Research ·De‐Chen Lin, Liang Xu, Ye Chen, Haiyan Yan, Masaharu Hazawa, Ngan Doan, Jonathan Said, Ling‐Wen Ding, Lizhen Liu, Henry Yang, Shizhu Yu, Michael Kahn, Dong Yin, H. Phillip Koeffler	2015	52
18	Extracellular vesicles, the cornerstone of next-generation cancer diagnosis? Seminars in Cancer Biology ·Jiayi Weng, Xiaoqiang Xiang, Ling‐Wen Ding, Andrea Li‐Ann Wong, Qi Zeng, Gautam Sethi, Lingzhi Wang, Soo Chin Lee, Boon Cher Goh	2021	49
19	Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma Nature Communications ·Ye Chen, Liang Xu, Anand Mayakonda, (unknown), Deepika Kanojia, Tuan Zea Tan, Pushkar Dakle, Ruby Yu‐Tong Lin, Xinyu Ke, Jonathan Said, Jianxiang Chen, Sigal Gery, Ling‐Wen Ding, Yan‐Yi Jiang, Angela Pang, Mark E. Puhaindran, Boon Cher Goh, H. Phillip Koeffler	2019	43
20	Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas Cancer Research ·Jian Pan, Tiago C. Silva, Nicole Gull, Qian Yang, Jasmine Plummer, Stephanie Chen, Kenji Daigo, Takao Hamakubo, Sigal Gery, Ling‐Wen Ding, Yan‐Yi Jiang, Shaoyan Hu, (unknown), En‐Min Li, Yanbing Ding, Samuel J. Klempner, Simon A. Gayther, Benjamin P. Berman, H. Phillip Koeffler, De‐Chen Lin	2020	40

About Ling‐Wen Ding

Ling‐Wen Ding is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 2.3k indexed citations. Recurring topics across this work include interferon and immune responses (6 papers), Ubiquitin and proteasome pathways (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related gene regulation (5 papers), MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers), Immunotherapy and Immune Responses (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Geriatrics and Gerontology (101 citations), Cancer Research (416 citations), Molecular Biology (1.4k citations), Oncology (377 citations) and Immunology (228 citations). Ling‐Wen Ding has collaborated with scholars based in Singapore, China and United States. Frequent co-authors include H. Phillip Koeffler, De‐Chen Lin, Boon Cher Goh, Xiaoqiang Xiang, Lingzhi Wang, Paul C. Ho, Pei Shi Ong, Qiao‐Yang Sun, Anand Mayakonda and Boxu Ren. Their work appears in journals such as Cancer Research, Advanced Materials, Blood, British Journal of Cancer and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ling‐Wen Ding

Impact in

Papers in i

In The Last Decade

Ling‐Wen Ding

Ling‐Wen Ding's Hit Papers

Peers

Countries citing papers authored by Ling‐Wen Ding

Fields of papers citing papers by Ling‐Wen Ding

All Works

About Ling‐Wen Ding

Explore authors with similar magnitude of impact

Papers in